Downloadable slides on treatment strategies for CLL including the most recent data on BTK inhibitors, BCL-2 inhibitor, PI3K inhibitors, and CAR T-cell therapy.
Results from a phase II trial of ibrutinib, lenalidomide, and rituximab in non-GCB DLBCL as reported by CCO from ASCO 2019
Downloadable patient resource on CLL including helpful web sites containing treatment information and supportive care, as well as questions to ask your doctor during office visits
Phase III CLL14 trial of venetoclax plus obinutuzumab in previously untreated patients with CLL and comorbidities as reported by CCO from ASCO 2019
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.